Abstract

Background. Modifiable factors in adulthood that explain the racial disparity in prostate cancer have not been identified. Because racial differences in utero that may account for this disparity are understudied, we investigated the association of maternal and neonate factors with cord blood telomere length, as a cumulative marker of cell proliferation and oxidative damage, by race. Further, we evaluated whether cord blood telomere length differs by race. Methods. We measured venous umbilical cord blood leukocyte relative telomere length by qPCR in 38 black and 38 white full-term male neonates. Using linear regression, we estimated geometric mean relative telomere length and tested for differences by race. Results. Black mothers were younger and had higher parity and black neonates had lower birth and placental weights. These factors were not associated with relative telomere length, even after adjusting for or stratifying by race. Relative telomere length in black (2.72) and white (2.73) neonates did not differ, even after adjusting for maternal or neonate factors (all p > 0.9). Conclusions. Maternal and neonate factors were not associated with cord blood telomere length, and telomere length did not differ by race. These findings suggest that telomere length at birth does not explain the prostate cancer racial disparity.

Highlights

  • The racial disparity in prostate cancer incidence and mortality rates is among the greatest across all cancer sites

  • Because racial differences in utero that may account for this disparity are understudied, we investigated the association of maternal and neonate factors with cord blood telomere length, as a cumulative marker of cell proliferation and oxidative damage, by race

  • The association between androstanediol glucuronide (AAG) and relative telomere length was similar in magnitude in black and white neonates (p-interaction = 0.9) but was statistically significant only in black neonates (p-trend = 0.01)

Read more

Summary

Introduction

The racial disparity in prostate cancer incidence and mortality rates is among the greatest across all cancer sites. Because racial differences in utero that may account for this disparity are understudied, we investigated the association of maternal and neonate factors with cord blood telomere length, as a cumulative marker of cell proliferation and oxidative damage, by race. We measured venous umbilical cord blood leukocyte relative telomere length by qPCR in 38 black and 38 white full-term male neonates. Black mothers were younger and had higher parity and black neonates had lower birth and placental weights These factors were not associated with relative telomere length, even after adjusting for or stratifying by race. Maternal and neonate factors were not associated with cord blood telomere length, and telomere length did not differ by race These findings suggest that telomere length at birth does not explain the prostate cancer racial disparity

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call